A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil
采用包括肿瘤表皮生长因子受体、p53、胸苷酸合成酶和二氢嘧啶脱氢酶在内的多因素方法预测接受5-氟尿嘧啶治疗的头颈癌患者的治疗结果。
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/sj.bjc.6690297
Etienne, M C; Pivot, X; Formento, J L; Bensadoun, R J; Formento, P; Dassonville, O; Francoual, M; Poissonnet, G; Fontana, X; Schneider, M; Demard, F; Milano, G
